Announcements Trials
Browse Landscape

Phase

Phase 2/3 2Phase EARLY_PHASE1 1Phase 2 1

Status

Recruiting 3Completed 1

Sponsor Class

INDUSTRY 4OTHER 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 209Neoplasms 119Breast Neoplasms 113Colorectal Neoplasms 100Prostatic Neoplasms 80Ovarian Neoplasms 79Neoplasm Metastasis 79Lung Neoplasms 70Multiple Myeloma 67Squamous Cell Carcinoma of Head and Neck 51Pancreatic Neoplasms 50Endometrial Neoplasms 50Recurrence 48Stomach Neoplasms 41Melanoma 41Leukemia, Lymphocytic, Chronic, B-Cell 41Carcinoma, Renal Cell 40Small Cell Lung Carcinoma 39Leukemia, Myeloid, Acute 35Urinary Bladder Neoplasms 32Lymphoma, Non-Hodgkin 32Parkinson Disease 4, Autosomal Dominant Lewy Body 30Triple Negative Breast Neoplasms 29Carcinoma, Hepatocellular 28Head and Neck Neoplasms 27Advanced Solid Tumors 27Lymphoma, Large B-Cell, Diffuse 26Lymphoma, Follicular 25Esophageal Neoplasms 24Lymphoma 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Cachexia × 30 days × Clear all
NCT06989437 2026-06-05

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Pfizer

Phase 2/3 Recruiting
982 enrolled
Gastrointestinal

Anorexia, Cachexia, Fatigue, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms, Weight Loss

NCT05546476 2026-06-03

PROACC-1

Pfizer

Phase 2 Completed
187 enrolled 24 charts
GastrointestinalThoracic

Anorexia, Cachexia, Carcinoma, Non-Small-Cell Lung, Fatigue, Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Weight Loss

NCT07112196 2026-05-20

VINCIT

CatalYm GmbH

Phase 2/3 Recruiting
518 enrolled

Anorexia, Cachexia, Neoplasms, Weight Loss

NCT06736275 2026-05-15

A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors

Jiangsu Nutai Biologics Co., Ltd

Phase EARLY_PHASE1 Recruiting
28 enrolled

Cachexia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡